Rechercher | MTSocial

Harshasharma Harshasharma Ajouter une nouvelle offre d'emploi Autre
2026-02-12 06:13:20 -

GLP-1 Receptor Agonists Obesity Drugs Market Overview: Key Drivers and Challenges
Executive Summary GLP-1 Receptor Agonists Obesity Drugs Market Size and Share Across Top Segments CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period This GLP-1 Receptor Agonists Obesity Drugs...

0 Commentaires 0 Parts 261 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Harshasharma Harshasharma Ajouter une nouvelle offre d'emploi Networking
2025-11-27 09:36:58 -

GLP-1 Receptor Agonists Obesity Drugs Market: Transforming Treatment Through Innovation
GLP-1 receptor agonists are shifting obesity treatment paradigms by offering clinically proven weight loss, appetite regulation, and metabolic benefits.As obesity rates continue rising globally, these drugs are drawing enormous attention from healthcare providers, regulators, and the pharmaceutical industry for their potential to reshape patient outcomes and market value. Get a full overview of...

0 Commentaires 0 Parts 829 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Shiv Mehara Ajouter une nouvelle offre d'emploi Health
2025-11-25 07:12:55 -

Polycystic Ovary Syndrome (PCOS) Treatment Market Trend Analysis
Introspective Market Research (IMR) announces a comprehensive analysis of the Global Polycystic Ovary Syndrome (PCOS) Treatment Market. PCOS, a complex endocrine disorder affecting reproductive-aged women, is a major driver in the women's health sector due to its lifelong implications for metabolic health and fertility. The market, valued at USD 1.5 Billion in 2023, is projected to witness...

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!